Methylnaltrindole
A selective delta-opioid receptor antagonist
Methylnaltrindole (MNTI) is a highly selective delta-opioid receptor antagonist. It is a synthetic compound that is used primarily in research settings to study the role of delta-opioid receptors in various physiological and pathological processes.
Pharmacology[edit | edit source]
Methylnaltrindole is known for its high affinity and selectivity for the delta-opioid receptor, which is one of the three main types of opioid receptors in the body, the others being mu and kappa receptors. The delta-opioid receptor is involved in modulating pain, mood, and other functions.
Mechanism of Action
Methylnaltrindole acts as an antagonist at the delta-opioid receptor, meaning it binds to the receptor but does not activate it, thereby blocking the action of endogenous opioids or other agonists that would normally activate the receptor. This makes it a valuable tool in research for understanding the specific roles of delta-opioid receptors without the confounding effects of activating other opioid receptors.
Research Applications[edit | edit source]
Methylnaltrindole is primarily used in preclinical research to explore the physiological and behavioral effects of delta-opioid receptor modulation. Studies have investigated its role in:
- Pain Management: Understanding how delta-opioid receptors contribute to pain perception and the potential for developing new analgesics that target these receptors.
- Mood Disorders: Exploring the involvement of delta-opioid receptors in mood regulation and their potential as targets for antidepressant therapies.
- Addiction: Investigating the role of delta-opioid receptors in addiction and the potential for developing treatments that mitigate addictive behaviors.
Chemical Properties[edit | edit source]
Methylnaltrindole is a complex organic compound with the chemical formula C26H30N2O4. It is structurally related to other opioid receptor ligands but is distinguished by its high selectivity for the delta-opioid receptor.
Safety and Handling[edit | edit source]
As with many research chemicals, methylnaltrindole should be handled with care in a laboratory setting. Appropriate safety measures, including the use of personal protective equipment and proper ventilation, should be employed to minimize exposure.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
